TrialThe Journal of urology2025

Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 Trial.

Angela M Stover et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.